Please login to the form below

Not currently logged in
Email:
Password:

NHS Life Sciences Innovation Delivery Board

The NHS has announced a new Life Sciences Innovation Delivery Board (LSIDB) to develop innovation in drugs and medical technologies in the UK

The NHS has announced the formation of a new Life Sciences Innovation Delivery Board (LSIDB) to develop innovation in drugs and medical technologies in the UK.

The announcement comes days after the decision to create the Centre for Workforce Intelligence which aims to offer guidance and control on the quality of workforce planning across the health service, as the NHS seeks to realise between £15bn and £20bn in efficiency savings.

According to a statement, the LSIDB, will aim to "increase the use of cost effective medicines and medical technologies, improve relationships between the life sciences sector and the NHS and increase the attractiveness of the UK as a site for clinical trials and product development."

The LSIDB will be made up of senior NHS leaders, regulators – including the National Institute for health and Clinical Excellence (NICE), senior policy makers and industry leaders from the field of life sciences.

The UK life sciences industry, which includes pharmaceuticals, medical technology and diagnostics, employs over 120,000 people and invests around £5bn in R&D in the UK. It is hoped the creation of the board will develop an effective partnership with the NHS, increasing quality and efficiency of service both from and between the two bodies.

Mike Farrar, chief executive of NHS North West and chairman of the LSIDB, says: "This is an exciting and important initiative for the NHS. It's hard to think of a more significant, mutually reliant relationship that is conducted under such difficult circumstances. The aim of this new Board is to enable the life sciences industry and the NHS to work together in collaboration for the benefit of patients. This can only be good news for all parties concerned."

1st April 2010

From: Healthcare

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics